Article
Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines.
Genome medicine - 18 Jul 2017
Alfaro Javier A, Ignatchenko Alexandr, Ignatchenko Vladimir, Sinha Ankit, Boutros Paul C, Kislinger Thomas
Abstract excerpt
BACKGROUND: Onco-proteogenomics aims to understand how changes in a cancer's genome influences its proteome. One challenge in integrating these molecular data is the identification of aberrant protein products from mass-spectrometry (MS) datasets, as traditional proteomic analyses only identify proteins from a reference sequence database. METHODS: We established proteomic workflows to detect peptide variants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
